Drug or treatment

Tagitanlimab clinical trials

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Pre-surgery sacituzumab govitecan plus tagitanlimab for operable head and neck squamous cell carcinoma

  This trial tests whether giving sacituzumab govitecan together with tagitanlimab before surgery helps people with resectable head and neck squamous cell carcinoma have better tumor responses and outcomes.

  Recruiting Phase 2 West China Hospital · Chengdu, Sichuan · NCT07492914

• Sacituzumab tirumotecan plus tagitanlimab for aggressive and neuroendocrine prostate cancer

  This trial tests whether combining sacituzumab tirumotecan with the immunotherapy tagitanlimab helps people with aggressive variant or neuroendocrine prostate cancer that has progressed after newer hormonal treatments.

  Recruiting Phase 2 Tianjin Medical University Second Hospital · Tianjin, Tianjin Municipality · NCT07179783

Quick answers

How many clinical trials of Tagitanlimab are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →